ReP USP - Resultado da busca

Artigo de periodico
Pharmacogenomics of statins: lipid response and other outcomes in Brazilian cohorts (2022)
Hernandez, Carolina Dagli ; Zhou, Yitian; Lauschke, Volker Martin; Genvigir, Fabiana Dalla Vecchia ; Hirata, Thiago Dominguez Crespo ; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Pharmacological Reports. Unidade: FCF
Subjects: ESTATINAS, FARMACOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HERNANDEZ, Carolina Dagli et al. Pharmacogenomics of statins: lipid response and other outcomes in Brazilian cohorts. Pharmacological Reports, v. 74, p. 47–66, 2022Tradução . . Disponível em: https://doi.org/10.1007/s43440-021-00319-y. Acesso em: 03 jul. 2024.
APA
Hernandez, C. D., Zhou, Y., Lauschke, V. M., Genvigir, F. D. V., Hirata, T. D. C., Hirata, M. H., & Hirata, R. D. C. (2022). Pharmacogenomics of statins: lipid response and other outcomes in Brazilian cohorts. Pharmacological Reports, 74, 47–66. doi:10.1007/s43440-021-00319-y
NLM
Hernandez CD, Zhou Y, Lauschke VM, Genvigir FDV, Hirata TDC, Hirata MH, Hirata RDC. Pharmacogenomics of statins: lipid response and other outcomes in Brazilian cohorts [Internet]. Pharmacological Reports. 2022 ; 74 47–66.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1007/s43440-021-00319-y
Vancouver
Hernandez CD, Zhou Y, Lauschke VM, Genvigir FDV, Hirata TDC, Hirata MH, Hirata RDC. Pharmacogenomics of statins: lipid response and other outcomes in Brazilian cohorts [Internet]. Pharmacological Reports. 2022 ; 74 47–66.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1007/s43440-021-00319-y
Artigo de periodico
TREML4 polymorphisms increase the mRNA in blood leukocytes in the progression of atherosclerosis (2022)
Duarte, Victor Hugo Rezende ; Cruz, Marina Sampaio; Bertolami, Adriana; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo ; Luchessi, André Ducati ; Silbiger, Vivian Nogueira
Source: Scientifc Reports. Unidade: FCF
Subjects: LEUCÓCITOS, ARTERIOSCLEROSE, BIOMARCADORES, CARDIOLOGIA, BIOLOGIA MOLECULAR, GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DUARTE, Victor Hugo Rezende et al. TREML4 polymorphisms increase the mRNA in blood leukocytes in the progression of atherosclerosis. Scientifc Reports, v. 12, p. 1-9 art. 18612, 2022Tradução . . Disponível em: https://doi.org/10.1038/s41598-022-22040-3. Acesso em: 03 jul. 2024.
APA
Duarte, V. H. R., Cruz, M. S., Bertolami, A., Hirata, M. H., Hirata, R. D. C., Luchessi, A. D., & Silbiger, V. N. (2022). TREML4 polymorphisms increase the mRNA in blood leukocytes in the progression of atherosclerosis. Scientifc Reports, 12, 1-9 art. 18612. doi:10.1038/s41598-022-22040-3
NLM
Duarte VHR, Cruz MS, Bertolami A, Hirata MH, Hirata RDC, Luchessi AD, Silbiger VN. TREML4 polymorphisms increase the mRNA in blood leukocytes in the progression of atherosclerosis [Internet]. Scientifc Reports. 2022 ; 12 1-9 art. 18612.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1038/s41598-022-22040-3
Vancouver
Duarte VHR, Cruz MS, Bertolami A, Hirata MH, Hirata RDC, Luchessi AD, Silbiger VN. TREML4 polymorphisms increase the mRNA in blood leukocytes in the progression of atherosclerosis [Internet]. Scientifc Reports. 2022 ; 12 1-9 art. 18612.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1038/s41598-022-22040-3
Artigo de periodico
Effect of statins on lipid metabolism-related microRNA expression in HepG2 cells (2021)
Cerda, Alvaro ; Bortolin, Raul Hernandes ; Manriquez, Victor; Salazar, Luis A ; Zambrano, Tomás ; Fajardo, Cristina Moreno ; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Pharmacological Reports. Unidade: FCF
Subjects: MICRORNAS, LIPÍDEOS, MICRORNAS, EXPRESSÃO GÊNICA, ESTATINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CERDA, Alvaro et al. Effect of statins on lipid metabolism-related microRNA expression in HepG2 cells. Pharmacological Reports, v. 73, p. 1-13 art. 868–880, 2021Tradução . . Disponível em: https://doi.org/10.1007/s43440-021-00241-3. Acesso em: 03 jul. 2024.
APA
Cerda, A., Bortolin, R. H., Manriquez, V., Salazar, L. A., Zambrano, T., Fajardo, C. M., et al. (2021). Effect of statins on lipid metabolism-related microRNA expression in HepG2 cells. Pharmacological Reports, 73, 1-13 art. 868–880. doi:10.1007/s43440-021-00241-3
NLM
Cerda A, Bortolin RH, Manriquez V, Salazar LA, Zambrano T, Fajardo CM, Hirata MH, Hirata RDC. Effect of statins on lipid metabolism-related microRNA expression in HepG2 cells [Internet]. Pharmacological Reports. 2021 ; 73 1-13 art. 868–880.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1007/s43440-021-00241-3
Vancouver
Cerda A, Bortolin RH, Manriquez V, Salazar LA, Zambrano T, Fajardo CM, Hirata MH, Hirata RDC. Effect of statins on lipid metabolism-related microRNA expression in HepG2 cells [Internet]. Pharmacological Reports. 2021 ; 73 1-13 art. 868–880.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1007/s43440-021-00241-3
Trabalho de evento-resumo periodico
Rare variants in CYP2C9 and CYP3A5 detected in patients with familial hypercholesterolemia with statin-related adverse events (2018)
Hernandez, Carolina Dagli; Borges, Jéssica Bassani; Los, Bruna; Faludi, André Arpad; Gonçalves, Rodrigo Marques; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Drug Metabolism and Personalized Therapy. Conference titles: Santorini Conference Systems Medicine and Personalised Health & Therapy. Unidade: FCF
Subjects: ESTATINAS, HIPERCOLESTEROLEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HERNANDEZ, Carolina Dagli et al. Rare variants in CYP2C9 and CYP3A5 detected in patients with familial hypercholesterolemia with statin-related adverse events. Drug Metabolism and Personalized Therapy. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: https://doi.org/10.1515/dmpt-2018-0024. Acesso em: 03 jul. 2024. , 2018
APA
Hernandez, C. D., Borges, J. B., Los, B., Faludi, A. A., Gonçalves, R. M., Hirata, M. H., & Hirata, R. D. C. (2018). Rare variants in CYP2C9 and CYP3A5 detected in patients with familial hypercholesterolemia with statin-related adverse events. Drug Metabolism and Personalized Therapy. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. doi:10.1515/dmpt-2018-0024
NLM
Hernandez CD, Borges JB, Los B, Faludi AA, Gonçalves RM, Hirata MH, Hirata RDC. Rare variants in CYP2C9 and CYP3A5 detected in patients with familial hypercholesterolemia with statin-related adverse events [Internet]. Drug Metabolism and Personalized Therapy. 2018 ; 33( 3): eA52-eA53.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1515/dmpt-2018-0024
Vancouver
Hernandez CD, Borges JB, Los B, Faludi AA, Gonçalves RM, Hirata MH, Hirata RDC. Rare variants in CYP2C9 and CYP3A5 detected in patients with familial hypercholesterolemia with statin-related adverse events [Internet]. Drug Metabolism and Personalized Therapy. 2018 ; 33( 3): eA52-eA53.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1515/dmpt-2018-0024
Artigo de periodico
Influence of CYP3A4 and CYP3A5 polymorphisms on tacrolimus and sirolimus exposure in stable kidney transplant recipients (2017)
Tamashiro, Erika Yumi; Felipe, Claudia R; Genvigir, Fabiana Dalla Vecchia ; Rodrigues, Alice Cristina ; Campos, Antony B.; Hirata, Rosario Dominguez Crespo ; Silva Junior, Helio Tedesco; Pestana, José O. Medina
Source: Drug Metabolism Personalized Theraphy. Unidade: FCF
Subjects: POLIMORFISMO, TRANSPLANTE DE RIM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TAMASHIRO, Erika Yumi et al. Influence of CYP3A4 and CYP3A5 polymorphisms on tacrolimus and sirolimus exposure in stable kidney transplant recipients. Drug Metabolism Personalized Theraphy, v. 32, n. 2, p. 89-95, 2017Tradução . . Disponível em: https://doi.org/10.1515/dmpt-2016-0036. Acesso em: 03 jul. 2024.
APA
Tamashiro, E. Y., Felipe, C. R., Genvigir, F. D. V., Rodrigues, A. C., Campos, A. B., Hirata, R. D. C., et al. (2017). Influence of CYP3A4 and CYP3A5 polymorphisms on tacrolimus and sirolimus exposure in stable kidney transplant recipients. Drug Metabolism Personalized Theraphy, 32( 2), 89-95. doi:10.1515/dmpt-2016-0036
NLM
Tamashiro EY, Felipe CR, Genvigir FDV, Rodrigues AC, Campos AB, Hirata RDC, Silva Junior HT, Pestana JOM. Influence of CYP3A4 and CYP3A5 polymorphisms on tacrolimus and sirolimus exposure in stable kidney transplant recipients [Internet]. Drug Metabolism Personalized Theraphy. 2017 ; 32( 2): 89-95.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1515/dmpt-2016-0036
Vancouver
Tamashiro EY, Felipe CR, Genvigir FDV, Rodrigues AC, Campos AB, Hirata RDC, Silva Junior HT, Pestana JOM. Influence of CYP3A4 and CYP3A5 polymorphisms on tacrolimus and sirolimus exposure in stable kidney transplant recipients [Internet]. Drug Metabolism Personalized Theraphy. 2017 ; 32( 2): 89-95.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1515/dmpt-2016-0036
Artigo de periodico
Pharmacogenetics of drug metabolizing enzymes in Brazilian populations (2014)
Cerda, Alvaro; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Drug Metabolism and Interactions. Unidade: FCF
Subjects: FARMACOGENÉTICA, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CERDA, Alvaro e HIRATA, Mario Hiroyuki e HIRATA, Rosario Dominguez Crespo. Pharmacogenetics of drug metabolizing enzymes in Brazilian populations. Drug Metabolism and Interactions, v. 29, n. 3, p. 153-177, 2014Tradução . . Disponível em: https://doi.org/10.1515/dmdi-2013-0067. Acesso em: 03 jul. 2024.
APA
Cerda, A., Hirata, M. H., & Hirata, R. D. C. (2014). Pharmacogenetics of drug metabolizing enzymes in Brazilian populations. Drug Metabolism and Interactions, 29( 3), 153-177. doi:10.1515/dmdi-2013-0067
NLM
Cerda A, Hirata MH, Hirata RDC. Pharmacogenetics of drug metabolizing enzymes in Brazilian populations [Internet]. Drug Metabolism and Interactions. 2014 ; 29( 3): 153-177.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1515/dmdi-2013-0067
Vancouver
Cerda A, Hirata MH, Hirata RDC. Pharmacogenetics of drug metabolizing enzymes in Brazilian populations [Internet]. Drug Metabolism and Interactions. 2014 ; 29( 3): 153-177.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1515/dmdi-2013-0067
Trabalho de evento-resumo periodico
Anti-inflammatory effects of cholesterol-lowering drugs in TNF'alfa'-induced endothelial cells (2012)
Cerda, Alvaro; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Drug Metabolism and Drug Interactions. Conference titles: Santorine Conference Biologie Prospective. Unidade: FCF
Subjects: CÉLULAS ENDOTELIAIS, ANTI-INFLAMATÓRIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CERDA, Alvaro e HIRATA, Mario Hiroyuki e HIRATA, Rosario Dominguez Crespo. Anti-inflammatory effects of cholesterol-lowering drugs in TNF'alfa'-induced endothelial cells. Drug Metabolism and Drug Interactions. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 03 jul. 2024. , 2012
APA
Cerda, A., Hirata, M. H., & Hirata, R. D. C. (2012). Anti-inflammatory effects of cholesterol-lowering drugs in TNF'alfa'-induced endothelial cells. Drug Metabolism and Drug Interactions. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Cerda A, Hirata MH, Hirata RDC. Anti-inflammatory effects of cholesterol-lowering drugs in TNF'alfa'-induced endothelial cells. Drug Metabolism and Drug Interactions. 2012 ; 27( 3): A23 res. B1.[citado 2024 jul. 03 ]
Vancouver
Cerda A, Hirata MH, Hirata RDC. Anti-inflammatory effects of cholesterol-lowering drugs in TNF'alfa'-induced endothelial cells. Drug Metabolism and Drug Interactions. 2012 ; 27( 3): A23 res. B1.[citado 2024 jul. 03 ]
Trabalho de evento-resumo periodico
Relationship of CYP2C9, CYP2C19 and ABCC3 polymorphisms and platelet response to aspirin and clopidogrel in acute coronary syndrome patients (2012)
Luchessi, André Ducati; Germano, J. F; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo ; Silbiger, Vivian Nogueira; Brion, M; Carracedo, A; Tanajura, Luiz Fernando Leite; Lima, P. H. O; Hirata, Thiago Dominguez Crespo; Sousa, A. G
Source: Drug Metabolism and Drug Interactions. Conference titles: Santorine Conference Biologie Prospective. Unidade: FCF
Subjects: POLIMORFISMO, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LUCHESSI, André Ducati et al. Relationship of CYP2C9, CYP2C19 and ABCC3 polymorphisms and platelet response to aspirin and clopidogrel in acute coronary syndrome patients. Drug Metabolism and Drug Interactions. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 03 jul. 2024. , 2012
APA
Luchessi, A. D., Germano, J. F., Hirata, M. H., Hirata, R. D. C., Silbiger, V. N., Brion, M., et al. (2012). Relationship of CYP2C9, CYP2C19 and ABCC3 polymorphisms and platelet response to aspirin and clopidogrel in acute coronary syndrome patients. Drug Metabolism and Drug Interactions. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Luchessi AD, Germano JF, Hirata MH, Hirata RDC, Silbiger VN, Brion M, Carracedo A, Tanajura LFL, Lima PHO, Hirata TDC, Sousa AG. Relationship of CYP2C9, CYP2C19 and ABCC3 polymorphisms and platelet response to aspirin and clopidogrel in acute coronary syndrome patients. Drug Metabolism and Drug Interactions. 2012 ; 27( 3): A28 res. B14.[citado 2024 jul. 03 ]
Vancouver
Luchessi AD, Germano JF, Hirata MH, Hirata RDC, Silbiger VN, Brion M, Carracedo A, Tanajura LFL, Lima PHO, Hirata TDC, Sousa AG. Relationship of CYP2C9, CYP2C19 and ABCC3 polymorphisms and platelet response to aspirin and clopidogrel in acute coronary syndrome patients. Drug Metabolism and Drug Interactions. 2012 ; 27( 3): A28 res. B14.[citado 2024 jul. 03 ]
Trabalho de evento-resumo periodico
Expression of inflammatory response genes in peripheral blood mononuclear cells from type 2 diabetes individuals treated with simvastatin and ezetimibe (2012)
Guimarães, E; Cerda, Alvaro; Genvigir, Fabiana Dalla Vecchia; Dórea, Egidio Lima; Pinto, Gelba Almeida; Gusukuma, Maria Cecília; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Drug Metabolism and Drug Interactions. Conference titles: Santorine Conference Biologie Prospective. Unidades: HU, FCF
Subjects: DIABETES MELLITUS NÃO INSULINO-DEPENDENTE, HIPERGLICEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUIMARÃES, E et al. Expression of inflammatory response genes in peripheral blood mononuclear cells from type 2 diabetes individuals treated with simvastatin and ezetimibe. Drug Metabolism and Drug Interactions. Berlin: Hospital Universitário, Universidade de São Paulo. . Acesso em: 03 jul. 2024. , 2012
APA
Guimarães, E., Cerda, A., Genvigir, F. D. V., Dórea, E. L., Pinto, G. A., Gusukuma, M. C., et al. (2012). Expression of inflammatory response genes in peripheral blood mononuclear cells from type 2 diabetes individuals treated with simvastatin and ezetimibe. Drug Metabolism and Drug Interactions. Berlin: Hospital Universitário, Universidade de São Paulo.
NLM
Guimarães E, Cerda A, Genvigir FDV, Dórea EL, Pinto GA, Gusukuma MC, Hirata MH, Hirata RDC. Expression of inflammatory response genes in peripheral blood mononuclear cells from type 2 diabetes individuals treated with simvastatin and ezetimibe. Drug Metabolism and Drug Interactions. 2012 ; 27( 3): A26 res. B8.[citado 2024 jul. 03 ]
Vancouver
Guimarães E, Cerda A, Genvigir FDV, Dórea EL, Pinto GA, Gusukuma MC, Hirata MH, Hirata RDC. Expression of inflammatory response genes in peripheral blood mononuclear cells from type 2 diabetes individuals treated with simvastatin and ezetimibe. Drug Metabolism and Drug Interactions. 2012 ; 27( 3): A26 res. B8.[citado 2024 jul. 03 ]
Trabalho de evento-resumo periodico
Clopidogrel downregulates TNF'alfa'-induced ICAM1 and IL8 expressions in endothelial cells (2012)
Cerda, Alvaro; Luchessi, Augusto Ducati; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Drug Metabolism and Drug Interactions. Conference titles: Santorine Conference Biologie Prospective. Unidade: FCF
Subjects: CÉLULAS ENDOTELIAIS, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CERDA, Alvaro et al. Clopidogrel downregulates TNF'alfa'-induced ICAM1 and IL8 expressions in endothelial cells. Drug Metabolism and Drug Interactions. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 03 jul. 2024. , 2012
APA
Cerda, A., Luchessi, A. D., Hirata, M. H., & Hirata, R. D. C. (2012). Clopidogrel downregulates TNF'alfa'-induced ICAM1 and IL8 expressions in endothelial cells. Drug Metabolism and Drug Interactions. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Cerda A, Luchessi AD, Hirata MH, Hirata RDC. Clopidogrel downregulates TNF'alfa'-induced ICAM1 and IL8 expressions in endothelial cells. Drug Metabolism and Drug Interactions. 2012 ; 27( 3): A24 res. B2.[citado 2024 jul. 03 ]
Vancouver
Cerda A, Luchessi AD, Hirata MH, Hirata RDC. Clopidogrel downregulates TNF'alfa'-induced ICAM1 and IL8 expressions in endothelial cells. Drug Metabolism and Drug Interactions. 2012 ; 27( 3): A24 res. B2.[citado 2024 jul. 03 ]
Artigo de periodico
Molecular mechanisms underlying statin effects on genes involved in the reverse cholesterol transport (2012)
Cerda, Alvaro; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Drug Metabolism and Drug Interactions. Unidade: FCF
Subjects: LIPOPROTEÍNAS LDL, COLESTEROL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CERDA, Alvaro e HIRATA, Mario Hiroyuki e HIRATA, Rosario Dominguez Crespo. Molecular mechanisms underlying statin effects on genes involved in the reverse cholesterol transport. Drug Metabolism and Drug Interactions, v. 27, n. 2, p. 101-111, 2012Tradução . . Disponível em: https://doi.org/10.1515/dmdi-2012-0007. Acesso em: 03 jul. 2024.
APA
Cerda, A., Hirata, M. H., & Hirata, R. D. C. (2012). Molecular mechanisms underlying statin effects on genes involved in the reverse cholesterol transport. Drug Metabolism and Drug Interactions, 27( 2), 101-111. doi:10.1515/dmdi-2012-0007
NLM
Cerda A, Hirata MH, Hirata RDC. Molecular mechanisms underlying statin effects on genes involved in the reverse cholesterol transport [Internet]. Drug Metabolism and Drug Interactions. 2012 ; 27( 2): 101-111.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1515/dmdi-2012-0007
Vancouver
Cerda A, Hirata MH, Hirata RDC. Molecular mechanisms underlying statin effects on genes involved in the reverse cholesterol transport [Internet]. Drug Metabolism and Drug Interactions. 2012 ; 27( 2): 101-111.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1515/dmdi-2012-0007
Artigo de periodico
Uric acid biorhythm, a feature of long-term variation in a clinical laboratory database (2012)
Andrade, Mauricio Pacheco de; Hirata, Rosario Dominguez Crespo ; Sandrini, Fabiano; Largura, Alvaro; Hirata, Mario Hiroyuki
Source: Clinical Chemistry and Laboratory Medicine. Unidade: FCF
Subjects: ÁCIDO ÚRICO, BANCO DE DADOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANDRADE, Mauricio Pacheco de et al. Uric acid biorhythm, a feature of long-term variation in a clinical laboratory database. Clinical Chemistry and Laboratory Medicine, v. 50, n. 5, p. 853-859, 2012Tradução . . Disponível em: https://doi.org/10.1515/cclm-2011-0150. Acesso em: 03 jul. 2024.
APA
Andrade, M. P. de, Hirata, R. D. C., Sandrini, F., Largura, A., & Hirata, M. H. (2012). Uric acid biorhythm, a feature of long-term variation in a clinical laboratory database. Clinical Chemistry and Laboratory Medicine, 50( 5), 853-859. doi:10.1515/cclm-2011-0150
NLM
Andrade MP de, Hirata RDC, Sandrini F, Largura A, Hirata MH. Uric acid biorhythm, a feature of long-term variation in a clinical laboratory database [Internet]. Clinical Chemistry and Laboratory Medicine. 2012 ; 50( 5): 853-859.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1515/cclm-2011-0150
Vancouver
Andrade MP de, Hirata RDC, Sandrini F, Largura A, Hirata MH. Uric acid biorhythm, a feature of long-term variation in a clinical laboratory database [Internet]. Clinical Chemistry and Laboratory Medicine. 2012 ; 50( 5): 853-859.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1515/cclm-2011-0150
Trabalho de evento-resumo periodico
Effects of pioglitazone on PPARG, TNFA and osteoprotegerin expression in leukocytes and bone turnover biomarkers in diabetic individuals (2010)
Himelfarb, Silvia Tchernin; Silva, F. A; Arazi, Simone Sorkin; Farjado, C. M; Oliveira, Raquel; Bertolami, Marcelo Chiara; Rezende, A. A; Bertolami, A; Faludi, A; Sampaio, M. F; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Source: Clinical Chemistry and Laboratory Medicine. Conference titles: Santorini Conference Biologie Prospective. Unidade: FCF
Subjects: DIABETES MELLITUS, BIOMARCADORES, LEUCÓCITOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HIMELFARB, Silvia Tchernin et al. Effects of pioglitazone on PPARG, TNFA and osteoprotegerin expression in leukocytes and bone turnover biomarkers in diabetic individuals. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 03 jul. 2024. , 2010
APA
Himelfarb, S. T., Silva, F. A., Arazi, S. S., Farjado, C. M., Oliveira, R., Bertolami, M. C., et al. (2010). Effects of pioglitazone on PPARG, TNFA and osteoprotegerin expression in leukocytes and bone turnover biomarkers in diabetic individuals. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Himelfarb ST, Silva FA, Arazi SS, Farjado CM, Oliveira R, Bertolami MC, Rezende AA, Bertolami A, Faludi A, Sampaio MF, Hirata RDC, Hirata MH. Effects of pioglitazone on PPARG, TNFA and osteoprotegerin expression in leukocytes and bone turnover biomarkers in diabetic individuals. Clinical Chemistry and Laboratory Medicine. 2010 ; 48( 8): A67 res. B12.[citado 2024 jul. 03 ]
Vancouver
Himelfarb ST, Silva FA, Arazi SS, Farjado CM, Oliveira R, Bertolami MC, Rezende AA, Bertolami A, Faludi A, Sampaio MF, Hirata RDC, Hirata MH. Effects of pioglitazone on PPARG, TNFA and osteoprotegerin expression in leukocytes and bone turnover biomarkers in diabetic individuals. Clinical Chemistry and Laboratory Medicine. 2010 ; 48( 8): A67 res. B12.[citado 2024 jul. 03 ]
Trabalho de evento-resumo periodico
Effects of lipid-lowering drugs on reverse cholesterol transport gene expressions in Caco-2 cells (2010)
Genvigir, Fabiana Dalla Vecchia; Rodrigues, Alice Cristina ; Hirata, Mario Hiroyuki ; Curi, Rui; Hirata, Rosario Dominguez Crespo
Source: Clinical Chemistry and Laboratory Medicine. Conference titles: Santorini Conference Biologie Prospective. Unidades: FCF, ICB
Subjects: EXPRESSÃO GÊNICA, COLESTEROL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GENVIGIR, Fabiana Dalla Vecchia et al. Effects of lipid-lowering drugs on reverse cholesterol transport gene expressions in Caco-2 cells. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 03 jul. 2024. , 2010
APA
Genvigir, F. D. V., Rodrigues, A. C., Hirata, M. H., Curi, R., & Hirata, R. D. C. (2010). Effects of lipid-lowering drugs on reverse cholesterol transport gene expressions in Caco-2 cells. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Genvigir FDV, Rodrigues AC, Hirata MH, Curi R, Hirata RDC. Effects of lipid-lowering drugs on reverse cholesterol transport gene expressions in Caco-2 cells. Clinical Chemistry and Laboratory Medicine. 2010 ; 48( 8): A66 res. B11.[citado 2024 jul. 03 ]
Vancouver
Genvigir FDV, Rodrigues AC, Hirata MH, Curi R, Hirata RDC. Effects of lipid-lowering drugs on reverse cholesterol transport gene expressions in Caco-2 cells. Clinical Chemistry and Laboratory Medicine. 2010 ; 48( 8): A66 res. B11.[citado 2024 jul. 03 ]
Trabalho de evento-resumo periodico
Clopidogrel response is affected by ABCC3 expression but not ABCB1 in CAD patients (2010)
Luchessi, André Ducati; Silbiger, Vivian Nogueira; Hirata, Rosario Dominguez Crespo ; Cerda, Alvaro; Carracedo, A; Brion, Marcel; Iñigues, A; Bravo, M. S; Bastos, G; Sousa, A. G. M. R; Hirata, Mario Hiroyuki
Source: Clinical Chemistry and Laboratory Medicine. Conference titles: Santorini Conference Biologie Prospective. Unidade: FCF
Assunto: EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LUCHESSI, André Ducati et al. Clopidogrel response is affected by ABCC3 expression but not ABCB1 in CAD patients. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 03 jul. 2024. , 2010
APA
Luchessi, A. D., Silbiger, V. N., Hirata, R. D. C., Cerda, A., Carracedo, A., Brion, M., et al. (2010). Clopidogrel response is affected by ABCC3 expression but not ABCB1 in CAD patients. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Luchessi AD, Silbiger VN, Hirata RDC, Cerda A, Carracedo A, Brion M, Iñigues A, Bravo MS, Bastos G, Sousa AGMR, Hirata MH. Clopidogrel response is affected by ABCC3 expression but not ABCB1 in CAD patients. Clinical Chemistry and Laboratory Medicine. 2010 ; 48( 8): A69 res. B19.[citado 2024 jul. 03 ]
Vancouver
Luchessi AD, Silbiger VN, Hirata RDC, Cerda A, Carracedo A, Brion M, Iñigues A, Bravo MS, Bastos G, Sousa AGMR, Hirata MH. Clopidogrel response is affected by ABCC3 expression but not ABCB1 in CAD patients. Clinical Chemistry and Laboratory Medicine. 2010 ; 48( 8): A69 res. B19.[citado 2024 jul. 03 ]
Trabalho de evento-resumo periodico
Polymorphism of the gene of Lep, LEPR, AdipoQ and IL-6 and possible involvement in obesity and diabetes mellitus in Brazilian population (2010)
Oliveira, Raquel; Genvigir, Fabiana Dalla Vecchia; Cerda, Alvaro; Dórea, Egidio Lima; Bernik, Marcia Martins Silveira; Jorge, M. E. I; Fajardo, Cristina Moreno ; Crema, Daniela; Machado, J. E. A; Martinez, M. B; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Clinical Chemistry and Laboratory Medicine. Conference titles: Santorini Conference Biologie Prospective. Unidades: HU, FCF
Subjects: POLIMORFISMO, DIABETES MELLITUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Raquel et al. Polymorphism of the gene of Lep, LEPR, AdipoQ and IL-6 and possible involvement in obesity and diabetes mellitus in Brazilian population. Clinical Chemistry and Laboratory Medicine. Berlin: Hospital Universitário, Universidade de São Paulo. . Acesso em: 03 jul. 2024. , 2010
APA
Oliveira, R., Genvigir, F. D. V., Cerda, A., Dórea, E. L., Bernik, M. M. S., Jorge, M. E. I., et al. (2010). Polymorphism of the gene of Lep, LEPR, AdipoQ and IL-6 and possible involvement in obesity and diabetes mellitus in Brazilian population. Clinical Chemistry and Laboratory Medicine. Berlin: Hospital Universitário, Universidade de São Paulo.
NLM
Oliveira R, Genvigir FDV, Cerda A, Dórea EL, Bernik MMS, Jorge MEI, Fajardo CM, Crema D, Machado JEA, Martinez MB, Hirata MH, Hirata RDC. Polymorphism of the gene of Lep, LEPR, AdipoQ and IL-6 and possible involvement in obesity and diabetes mellitus in Brazilian population. Clinical Chemistry and Laboratory Medicine. 2010 ; 48( 8): A56-A56 res. A24.[citado 2024 jul. 03 ]
Vancouver
Oliveira R, Genvigir FDV, Cerda A, Dórea EL, Bernik MMS, Jorge MEI, Fajardo CM, Crema D, Machado JEA, Martinez MB, Hirata MH, Hirata RDC. Polymorphism of the gene of Lep, LEPR, AdipoQ and IL-6 and possible involvement in obesity and diabetes mellitus in Brazilian population. Clinical Chemistry and Laboratory Medicine. 2010 ; 48( 8): A56-A56 res. A24.[citado 2024 jul. 03 ]
Trabalho de evento-resumo periodico
Atorvastatin down-regulates APOE mRNA expression in postmenopausal women (2010)
Issa, Mustafa Hassan; Cerda, Alvaro; Genvigir, Fabiana Dalla Vecchia; Cavalli, Selma Andrea; Bertolami, Marcelo Chiara; Faludi, André Arpad; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Clinical Chemistry and Laboratory Medicine. Conference titles: Santorini Conference Biologie Prospective. Unidade: FCF
Subjects: PÓS-MENOPAUSA, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ISSA, Mustafa Hassan et al. Atorvastatin down-regulates APOE mRNA expression in postmenopausal women. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 03 jul. 2024. , 2010
APA
Issa, M. H., Cerda, A., Genvigir, F. D. V., Cavalli, S. A., Bertolami, M. C., Faludi, A. A., et al. (2010). Atorvastatin down-regulates APOE mRNA expression in postmenopausal women. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Issa MH, Cerda A, Genvigir FDV, Cavalli SA, Bertolami MC, Faludi AA, Hirata MH, Hirata RDC. Atorvastatin down-regulates APOE mRNA expression in postmenopausal women. Clinical Chemistry and Laboratory Medicine. 2010 ; 48( 8): A68 res. B15.[citado 2024 jul. 03 ]
Vancouver
Issa MH, Cerda A, Genvigir FDV, Cavalli SA, Bertolami MC, Faludi AA, Hirata MH, Hirata RDC. Atorvastatin down-regulates APOE mRNA expression in postmenopausal women. Clinical Chemistry and Laboratory Medicine. 2010 ; 48( 8): A68 res. B15.[citado 2024 jul. 03 ]
Trabalho de evento-resumo periodico
Influence of polymorphisms and cholesterol-lowering treatment on SCARB1 mRNA expression (2010)
Cerda, Alvaro; Genvigir, Fabiana Dalla Vecchia; Rodrigues, Alice Cristina ; Arazi, Simone Sorkin; Oliveira, Raquel; Dórea, Egidio Lima; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Clinical Chemistry and Laboratory Medicine. Conference titles: Santorini Conference Biologie Prospective. Unidades: HU, FCF
Subjects: POLIMORFISMO, COLESTEROL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CERDA, Alvaro et al. Influence of polymorphisms and cholesterol-lowering treatment on SCARB1 mRNA expression. Clinical Chemistry and Laboratory Medicine. Berlin: Hospital Universitário, Universidade de São Paulo. . Acesso em: 03 jul. 2024. , 2010
APA
Cerda, A., Genvigir, F. D. V., Rodrigues, A. C., Arazi, S. S., Oliveira, R., Dórea, E. L., et al. (2010). Influence of polymorphisms and cholesterol-lowering treatment on SCARB1 mRNA expression. Clinical Chemistry and Laboratory Medicine. Berlin: Hospital Universitário, Universidade de São Paulo.
NLM
Cerda A, Genvigir FDV, Rodrigues AC, Arazi SS, Oliveira R, Dórea EL, Hirata MH, Hirata RDC. Influence of polymorphisms and cholesterol-lowering treatment on SCARB1 mRNA expression. Clinical Chemistry and Laboratory Medicine. 2010 ; 48( 8): A64-A64 res. B4.[citado 2024 jul. 03 ]
Vancouver
Cerda A, Genvigir FDV, Rodrigues AC, Arazi SS, Oliveira R, Dórea EL, Hirata MH, Hirata RDC. Influence of polymorphisms and cholesterol-lowering treatment on SCARB1 mRNA expression. Clinical Chemistry and Laboratory Medicine. 2010 ; 48( 8): A64-A64 res. B4.[citado 2024 jul. 03 ]
Artigo de periodico
Direct detection of Mycobacterium bovis in bovine lymph nodes by PCR (2009)
Cardoso, Marco Antonio; Cardoso, Rosilene Fressatti; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki ; Leite, Clarice Queico Fujimura; Santos, Adolfo Carlos Barreto; Siqueira, Vera Lúcia Dias; Okano, W.; Rocha, N. S.; Lonardoni, Maria Valdrinez Campana
Source: Zoonoses and Public Health. Unidade: FCF
Subjects: MYCOBACTERIUM BOVIS, TUBERCULOSE, REAÇÃO EM CADEIA POR POLIMERASE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARDOSO, Marco Antonio et al. Direct detection of Mycobacterium bovis in bovine lymph nodes by PCR. Zoonoses and Public Health, v. 56, n. 8. p. 465-470, 2009Tradução . . Disponível em: http://www3.interscience.wiley.com/cgi-bin/fulltext/121641598/PDFSTART. Acesso em: 03 jul. 2024.
APA
Cardoso, M. A., Cardoso, R. F., Hirata, R. D. C., Hirata, M. H., Leite, C. Q. F., Santos, A. C. B., et al. (2009). Direct detection of Mycobacterium bovis in bovine lymph nodes by PCR. Zoonoses and Public Health, 56( 8. p. 465-470). Recuperado de http://www3.interscience.wiley.com/cgi-bin/fulltext/121641598/PDFSTART
NLM
Cardoso MA, Cardoso RF, Hirata RDC, Hirata MH, Leite CQF, Santos ACB, Siqueira VLD, Okano W, Rocha NS, Lonardoni MVC. Direct detection of Mycobacterium bovis in bovine lymph nodes by PCR [Internet]. Zoonoses and Public Health. 2009 ; 56( 8. p. 465-470):[citado 2024 jul. 03 ] Available from: http://www3.interscience.wiley.com/cgi-bin/fulltext/121641598/PDFSTART
Vancouver
Cardoso MA, Cardoso RF, Hirata RDC, Hirata MH, Leite CQF, Santos ACB, Siqueira VLD, Okano W, Rocha NS, Lonardoni MVC. Direct detection of Mycobacterium bovis in bovine lymph nodes by PCR [Internet]. Zoonoses and Public Health. 2009 ; 56( 8. p. 465-470):[citado 2024 jul. 03 ] Available from: http://www3.interscience.wiley.com/cgi-bin/fulltext/121641598/PDFSTART
Trabalho de evento-resumo periodico
Scavenger receptor class B type I polymorphisms and its relation with serum lipids profile and response to atorvastatin in Brazilian individuals (2008)
Cerda, Alvaro; Arazi, Simone Sorkin; Genvigir, Fabiana Dalla Vecchia; Hirata, Mario Hiroyuki ; Dórea, Egidio Lima; Bernik, Marcia Martins Silveira; Hirata, Rosario Dominguez Crespo
Source: Clinical Chemistry and Laboratory Medicine. Conference titles: International Congress of Clinical Chemistry and Laboratory Medicine/IFCC-WorldLab. Unidades: FCF, HU
Subjects: POLIMORFISMO, FARMACOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CERDA, Alvaro et al. Scavenger receptor class B type I polymorphisms and its relation with serum lipids profile and response to atorvastatin in Brazilian individuals. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 03 jul. 2024. , 2008
APA
Cerda, A., Arazi, S. S., Genvigir, F. D. V., Hirata, M. H., Dórea, E. L., Bernik, M. M. S., & Hirata, R. D. C. (2008). Scavenger receptor class B type I polymorphisms and its relation with serum lipids profile and response to atorvastatin in Brazilian individuals. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Cerda A, Arazi SS, Genvigir FDV, Hirata MH, Dórea EL, Bernik MMS, Hirata RDC. Scavenger receptor class B type I polymorphisms and its relation with serum lipids profile and response to atorvastatin in Brazilian individuals. Clinical Chemistry and Laboratory Medicine. 2008 ; 46 ( S1): S571 res. W202.[citado 2024 jul. 03 ]
Vancouver
Cerda A, Arazi SS, Genvigir FDV, Hirata MH, Dórea EL, Bernik MMS, Hirata RDC. Scavenger receptor class B type I polymorphisms and its relation with serum lipids profile and response to atorvastatin in Brazilian individuals. Clinical Chemistry and Laboratory Medicine. 2008 ; 46 ( S1): S571 res. W202.[citado 2024 jul. 03 ]

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Conference titles

Funding Agencies

Indexado em

Non normalized affiliation